Primary hypothyroidism. Other specified hypothyroidism, Hypothyroidism, unspecified
Conditions
Interventions
8 weeks treatment with levothyroxine dose control with the Company, iran hormone and 8 weeks treatment with levothyroxine plus 500 milligrams of vitamin C daily morning fasting in the 200 cc model man
Treatment - Drugs
Sponsors
Vice Chancellor for research Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: TSH level between 0.5 and 4.5 micrograms per liter; taking levothyroxine dose for at least 6 months without changes. Exclusion criteria: thyroid cancer; pregnant or nursing; taking OCP or estrogen and testosterone during 3 months ago; chronic GI disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T3, T4. Timepoint: Arrival, 8 weeks after treatment. Method of measurement: In ng / dl using a blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| TSH. Timepoint: Arrival, 8 weeks after treatment. Method of measurement: In U/ml using a blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kazemzad Hamid
Arak University of Medical sceinces
Outcome results
None listed